Michael Rosenblatt - 12 May 2021 Form 4 Insider Report for Rubius Therapeutics, Inc. (RUBY)

Role
Director
Signature
/s/ Joanne M. Protano, Attorney-in-Fact
Issuer symbol
RUBY
Transactions as of
12 May 2021
Transactions value $
$0
Form type
4
Filing time
13 May 2021, 20:35:07 UTC
Next filing
14 May 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RUBY Stock Option (Right to Buy) Award $0 +25K $0.00 25K 12 May 2021 Common Stock 25K $23.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service.